These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2686067)

  • 21. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal effects of drugs used in the treatment of portal hypertension.
    Henriksen JH; Ring-Larsen H
    Hepatology; 1993 Sep; 18(3):688-95. PubMed ID: 8103034
    [No Abstract]   [Full Text] [Related]  

  • 24. The kidney in hypertension.
    Wright JR; Kalra PA
    Practitioner; 2001 Jan; 245(1618):41-6. PubMed ID: 11220011
    [No Abstract]   [Full Text] [Related]  

  • 25. A comprehensive review of antihypertensive agents providing renal protection.
    Kalus JS; White CM
    Conn Med; 2001 Oct; 65(10):587-91. PubMed ID: 11702517
    [No Abstract]   [Full Text] [Related]  

  • 26. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
    Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension update for the 1980s.
    Lowenthal DT; Swartz CD
    Prim Care; 1985 Mar; 12(1):101-15. PubMed ID: 2859624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
    Morita T; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blockers in hypertension. Is there still a controversy?
    Izzo JL
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):1-5. PubMed ID: 16640168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clevidipine: a novel ultra-short-acting calcium antagonist.
    Prlesi L; Cheng-Lai A
    Cardiol Rev; 2009; 17(3):147-52. PubMed ID: 19384089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current problems in hypotensive treatment].
    Sznajderman M
    Wiad Lek; 1983 Mar; 36(5):413-24. PubMed ID: 6135281
    [No Abstract]   [Full Text] [Related]  

  • 38. [Calcium antagonist and diurnal blood pressure variation].
    Kabutoya T; Kario K
    Clin Calcium; 2005 Oct; 15(10):1631-41. PubMed ID: 16199908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kidney function and the effectiveness of hypotensive therapy of patients with hypertension].
    Tikhonov VP; Bol'shakova RKh
    Ter Arkh; 1986; 58(8):73-6. PubMed ID: 3764766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.